-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate, also known as AICAR, is a chemical compound that has been widely studied for its potential medicinal properties.
It has been found to have anti-diabetic, anti-inflammatory, and cardioprotective effects, among others.
As a result, it has attracted significant attention in the chemical industry as a potential starting material for the development of new drugs.
Upstream Products
The upstream products of 2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate are mainly raw materials that are used in the production of the compound.
These raw materials include acetic acid, 2-amino-6-oxo-1H-purine-7-(6H)-sulfonic acid, and methanol, among others.
These raw materials are typically sourced from chemical manufacturers or suppliers and are then used in the production of AICAR.
Downstream Products
The downstream products of 2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate are mainly finished products that are derived from the compound.
These products include pharmaceuticals, nutraceuticals, and cosmeceuticals, among others.
These products are typically developed by pharmaceutical companies, biotech firms, and research institutions, among others, who use AICAR as a starting material for the development of new drugs or health products.
Pharmaceuticals
Pharmaceuticals are one of the main downstream products of 2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate.
The compound has been found to have anti-diabetic effects, and it has been studied for its potential use in the treatment of type 2 diabetes.
Research has shown that AICAR can stimulate insulin secretion in pancreatic beta cells, improve insulin sensitivity in muscle and fat tissues, and reduce fasting glucose levels in diabetic animals.
As a result, pharmaceutical companies have been interested in developing drugs based on AICAR for the treatment of diabetes.
Nutraceuticals
Nutraceuticals are another important downstream product of 2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate.
Nutraceuticals are food or dietary supplements that are believed to have health benefits.
AICAR has been found to have anti-inflammatory and cardioprotective effects, among others, and it has been studied for its potential use in the prevention and treatment of heart disease.
As a result, nutraceutical companies have been interested in developing products based on AICAR for the prevention and treatment of heart disease.
Cosmeceuticals
Cosmeceuticals are yet another important downstream product of 2-((2-Acetamido-6-oxo-1H-purin-7(6H)-yl)methoxy)ethyl acetate.
Cosmeceuticals are cosmetic products that are believed to have health benefits.
AICAR has been found to have anti-aging effects, and it has been studied for its potential use in the prevention and treatment of skin aging.
As a result, cosmeceutical companies have been interested in developing products based on AICAR for the prevention and treatment of skin aging.
Patents
Patents are an important aspect of the chemical industry, and they play a critical role in the development of new products based on AICAR.
Companies and research institutions interested in developing new products based on AICAR must file patents to protect their intellectual property and prevent others from copying their technology.
As
